Ralda Nehme, director of Broad’s stem cell program, talks about how stem cells can be a model for disease in a dish and what scientists can learn from these experiments.
New model system allows researchers to study the influence of genetic background on brain cells' responses to neurotoxins, disease mutations, and potential therapeutics
Tightly synchronized genetic changes in two types of brain cells may underlie cognitive impairment in both conditions, offering potential therapeutic clues.
Khalid Shakir talks about his work analyzing large single-cell datasets, his excitement around AI, and the importance of mentorship and community in science.
Stanley Center director Steve Hyman talks about a new report he co-authored that explores the obstacles in developing new treatments and how to overcome them
Two Broad research teams use spatial transcriptomics to create detailed atlases of the mouse nervous system, paving the way for similar efforts in humans.
A study of a genetic mouse model of schizophrenia supports two long-debated hypotheses, and unveils additional new clues about the biological roots of the disorder.